In approximately 50% of all patients with de novo AML, both the CD34+/CD38+ and the CD34+/CD38− cell subsets express the C‐type lectin protein‐1, CLL‐1 (CD371).34 This evidence concerns the gene CD34 and acute myeloid leukemia.